FilingReader Intelligence

J.B. Chemicals & Pharmaceuticals to consider Q2 and H1 unaudited financial results

October 24, 2025 at 05:49 AM UTC•By FilingReader AI

J.B. Chemicals & Pharmaceuticals Limited announced a board of directors meeting scheduled for November 11, 2025. The primary agenda for this meeting is to consider and approve the unaudited financial results for the quarter and half-year ended September 30, 2025.

The intimation was made under Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Sandeep Phadnis, vice president - secretarial & company secretary, signed the announcement on October 24, 2025.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

Primary Source Document

JB Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2025 ,inter alia, to consider and approve the unaudited ....October 24, 2025 at 05:41 AM UTC

J.B. Chemicals & Pharmaceuticals

BSE:JBCHEPHARM•Bombay Stock Exchange

RSS feed for J.B. Chemicals & Pharmaceuticals

News Alerts

Get instant email alerts when J.B. Chemicals & Pharmaceuticals publishes news

Free account required • Unsubscribe anytime

Browse RSS Feeds

Filing Activity Timeline

View Complete Filing History →